Physician profile
Jorge A Adames
NPI 1447342381
$987.10
in general payments reported to CMS, 2019-2025
10 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.24 · 2022: $98.92 · 2023: $325 · 2024: $344 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $743 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $742.95 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $280.36 | 2023-2025 | Enhertu, Injectafer, Datroway |
| Novartis Pharmaceuticals Corporation | $126.09 | 2022-2024 | |
| Jazz Pharmaceuticals INC. | $125.00 | 2024 | |
| Springworks Therapeutics, INC. | $122.55 | 2024 | Ogsiveo |
| Incyte Corporation | $99.99 | 2023 | |
| Caris Mpi, INC. | $95.77 | 2025 | Mi Cancer Seek |
| Amgen INC. | $80.95 | 2021-2023 | Lumakras |
| Gilead Sciences, INC. | $23.67 | 2023 | Trodelvy |
| E.R. Squibb & Sons, L.L.C. | $19.35 | 2025 | Opdivo |
| Janssen Biotech, INC. | $13.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Adames listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.